文献速递系统性红斑狼疮

多医疗场景下狼疮肾炎筛查、诊断与管理的医疗质量评估

Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Health Care Settings.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-05-14

基于加州狼疮流行病学研究250例狼疮患者数据,评估25个临床站点对狼疮肾炎(LN)筛查、诊断和治疗8项质量指标的完成情况。无LN患者总体完成率54%,LN患者80%;学术机构在筛查和治疗指标上均优于社区诊所。

要点

  • 无LN患者筛查指标完成率低,仅42%接受肾炎筛查实验室检查。
  • LN患者管理指标完成率较高,至少81%接受适当治疗。
  • 学术机构在LN筛查和治疗指标上均显著优于社区诊所。

核心结论

  • LN管理相关质量指标完成率相对较高,但无肾炎患者的狼疮医疗质量存在差距,社区场景尤为明显。

研究设计与样本

  • 基于加州狼疮流行病学研究,分析250例狼疮患者医疗记录、医生检查与患者访谈数据,覆盖25个临床站点,采用广义估计方程调整人口学、疾病严重度和执业特征。

主要发现

  • 148例无LN患者中,42%接受肾炎筛查实验室检查,38%接受狼疮活动性血清学检查,81%每6个月检查血压。
  • 102例LN患者中,67%及时接受肾活检,至少81%接受适当治疗,78%在诊断后1年内达到目标血压。
  • 无LN患者总体质量指标完成率为54%,LN患者为80%。
  • 学术机构筛查指标完成率为63.4-73%,社区诊所为37.9-38.4%。
  • LN患者治疗指标完成率学术机构为84.1-85.2%,社区诊所为54.8-60.2%。

临床怎么用

  • 应重点关注无肾炎狼疮患者的筛查质量,尤其在社区诊所加强肾炎筛查实验室检查和血清学监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined quality measures for screening, diagnosis, and treatment of lupus nephritis (LN) among participants of the California Lupus Epidemiology Study across 25 different clinical sites to identify gaps in quality of care. METHODS: Data from 250 participants with lupus were analyzed across 3 sources (medical records, physician examination, and patient interviews). Overall performance on 8 quality measures was calculated separately for participants with and without LN. We used generalized estimating equations in which the outcome was performance on measures, adjusting for participant demographics, lupus disease severity, and practice characteristics. RESULTS: Of 148 patients without LN, 42% underwent screening laboratory tests for nephritis, 38% underwent lupus activity serum studies, and 81% had their blood pressure checked every 6 months. Of 102 LN patients, 67% had a timely kidney biopsy, at least 81% had appropriate treatment, and 78% achieved target blood pressure within 1 year of diagnosis. Overall performance in participants across quality measures was 54% (no LN) and 80% (LN). Significantly higher overall performance for screening measures for LN was seen at academic (63.4-73%) versus community clinics (37.9-38.4%). Similarly, among those with LN, higher performance in academic (84.1-85.2%) versus community clinics (54.8-60.2%) was observed for treatment measures. CONCLUSION: In this quality-of-care analysis across 25 diverse clinical settings, we found relatively high performance on measures for management of LN. However, future work should focus on bridging the gaps in lupus quality of care for patients without nephritis, particularly in community settings.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Aggarwal I, Li J, Trupin L, et al. Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Health Care Settings. Arthritis Care Res (Hoboken). 2020. PMID: 31058460. doi:10.1002/acr.23915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。